Ypsomed AG Injection Device with Improved Conveying Element Patent Application

The European Patent Office published patent application EP4159257A1 for an injection device with improved conveying element. The application, filed by Ypsomed AG of Switzerland, names six inventors and covers medical injection device technology under IPC classifications A61M 5/20, A61M 5/24, and A61M 5/315. The application is designated for validation in 28 European contracting states.

For affected parties including medical device manufacturers and pharmaceutical companies, this publication represents an administrative milestone in the patent prosecution process. Third parties have an opportunity to file observations or oppose the application during the examination phase. The geographic scope covers major European markets where the patent may be validated if granted.